FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sandoz Amoxicillin Capsules 500 mg Recall

Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc

Sandoz Incorporated · Broomfield, CO

Risk level
Class II
Reported by FDA
May 1, 2013
Recall ID
D-268-2013
Check your lot numberHow we source this data

Summary

Sandoz recalled Amoxicillin Capsules 500 mg starting Apr 18, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-268-2013 on May 1, 2013. Reason: Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh. Status: Terminated.

Why it was recalled

Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.

Product description

Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only. Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.

Lot numbers, UPCs & expiration codes

CK2003, CK2004 exp. 04/15, CR4110, CR4111, CS2983, CS2986, CS2988, CS2989, CS2990, CS2991, CS2992, CS2993, CS2994 exp. 07/15, CK3616, CK3617 exp. 04/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-268-2013
Classification
Class II
Status
Terminated
Recall initiated
Apr 18, 2013
FDA report date
May 1, 2013
Quantity
8286 x 30 ct, 37108 x 500 ct. bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Incorporated

Original FDA data

Every field from FDA enforcement report D-268-2013, exactly as published.

Show all FDA fields
City
Broomfield
State
CO
Status
Terminated
Country
United States
Event ID
64936
Address
2555 W Midway Blvd
Code information
CK2003, CK2004 exp. 04/15, CR4110, CR4111, CS2983, CS2986, CS2988, CS2989, CS2990, CS2991, CS2992, CS2993, CS2994 exp. 07/15, CK3616, CK3617 exp. 04/15
Postal code
80020-1632
Report date
May 1, 2013
Product type
Drugs
Recall number
D-268-2013
Classification
Class II
Recalling firm
Sandoz Incorporated
Product quantity
8286 x 30 ct, 37108 x 500 ct. bottles
Termination date
Feb 26, 2014
Reason for recall
Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only. Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.
Distribution pattern
Nationwide
Recall initiation date
Apr 18, 2013
Initial firm notification
Letter
Center classification date
Apr 23, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-268-2013, published May 1, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls